Form 8-K - Current report:
SEC Accession No. 0001193125-25-125153
Filing Date
2025-05-22
Accepted
2025-05-22 17:15:05
Documents
13
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100783d8k.htm   iXBRL 8-K 43101
2 EX-10.1 d100783dex101.htm EX-10.1 130045
  Complete submission text file 0001193125-25-125153.txt   325202

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eq-20250521.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20250521_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20250521_pre.xml EX-101.PRE 11262
16 EXTRACTED XBRL INSTANCE DOCUMENT d100783d8k_htm.xml XML 3667
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 25978253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)